Atlas Trials

Effects of Empagliflozin in Reducing Oxidative Stress After Kidney Transplantation

Clinical trial NCT04918407 · COMPLETED

Trial details

NCT number
NCT04918407
Sponsor
Shahid Beheshti University of Medical Sciences
Status
COMPLETED
Phase
Not Applicable
Study type
INTERVENTIONAL
Kidney Transplant; Complications
Start date
2022-01-01
Primary completion
2025-07-05
Enrollment
40

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.